These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11360997)

  • 1. Inhibition effects of benactyzine and drofenine on human serum butyrylcholinesterase.
    Bodur E; Cokuğraş AN; Tezcan EF
    Arch Biochem Biophys; 2001 Feb; 386(1):25-9. PubMed ID: 11360997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Ni(2+), Co(2+), and Mn(2+) on desensitized butyrylcholinesterase prepared from human serum.
    Cengiz D; Cokugras AN; Tezcan EF
    Biol Trace Elem Res; 2003; 93(1-3):55-62. PubMed ID: 12835490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of Ni2+, Co2+, and Mn2+ on human serum butyrylcholinesterase.
    Cokuğraş AN; Cengiz D; Tezcan EF
    J Protein Chem; 2003 Aug; 22(6):585-9. PubMed ID: 14703992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Horse serum butyrylcholinesterase kinetics: a molecular mechanism based on inhibition studies with dansylaminoethyltrimethylammonium.
    Cauet G; Friboulet A; Thomas D
    Biochem Cell Biol; 1987 Jun; 65(6):529-35. PubMed ID: 3426832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amitriptyline: a potent inhibitor of butyrylcholinesterase from human serum.
    Cokuğraş AN; Tezcan EF
    Gen Pharmacol; 1997 Nov; 29(5):835-8. PubMed ID: 9347335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of indole-3-acetic acid on human and horse serum butyrylcholinesterase.
    Bodur E; Cokugras AN
    Chem Biol Interact; 2005 Dec; 157-158():375-8. PubMed ID: 16429500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the inhibitory effect of abamectin on mammalian butyrylcholinesterase: Enzyme kinetic and molecular docking studies.
    Teralı K; Dalmizrak O; Hoti Q; Ozer N
    J Environ Sci Health B; 2018; 53(11):713-718. PubMed ID: 29883250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
    Katalinić M; Rusak G; Domaćinović Barović J; Sinko G; Jelić D; Antolović R; Kovarik Z
    Eur J Med Chem; 2010 Jan; 45(1):186-92. PubMed ID: 19879672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.
    Amitai G; Moorad D; Adani R; Doctor BP
    Biochem Pharmacol; 1998 Aug; 56(3):293-9. PubMed ID: 9744565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase.
    Gatley SJ
    Biochem Pharmacol; 1991 Apr; 41(8):1249-54. PubMed ID: 2009099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase.
    Biberoglu K; Tacal Ö; Akbulut H
    Arch Biochem Biophys; 2011 Jul; 511(1-2):64-8. PubMed ID: 21530486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition kinetics of human serum butyrylcholinesterase by Cd2+, Zn2+ and Al3+: comparison of the effects of metal ions on cholinesterases.
    Sarkarati B; Cokuğraş AN; Tezcan EF
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1999 Feb; 122(2):181-90. PubMed ID: 10190043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of some aspects of antianaphylactic effect of amizie and diaminophen].
    Mel'nik AN
    Farmakol Toksikol; 1967; 30(2):148-52. PubMed ID: 4971064
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of binding points of methylene blue and cationic phenoxazine dyes on human butyrylcholinesterase.
    Sezgin Z; Biberoglu K; Chupakhin V; Makhaeva GF; Tacal O
    Arch Biochem Biophys; 2013 Apr; 532(1):32-8. PubMed ID: 23353050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toluidine blue O is a potent inhibitor of human cholinesterases.
    Biberoglu K; Tek MY; Ghasemi ST; Tacal O
    Arch Biochem Biophys; 2016 Aug; 604():57-62. PubMed ID: 27296777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
    J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cholinesterase activity by tetrahydroaminoacridine and the hemisuccinate esters of tocopherol and cholesterol.
    Chelliah J; Smith JD; Fariss MW
    Biochim Biophys Acta; 1994 May; 1206(1):17-26. PubMed ID: 8186246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.
    Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.